Primum non nocere: Are we ready for POLE testing in endometrial cancer?
- PMID: 28947175
- PMCID: PMC5705034
- DOI: 10.1016/j.ygyno.2017.09.015
Primum non nocere: Are we ready for POLE testing in endometrial cancer?
Keywords: Endometrial cancer; Molecular classification; POLE testing.
References
-
- Talhouk A, McConechy MK, Leung S, Yang W, Lum A, Senz J, et al. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer. Cancer. 2017 - PubMed
-
- Meng B, Hoang LN, McIntyre JB, Duggan MA, Nelson GS, Lee CH, et al. POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium. Gynecol Oncol. 2014 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources